Molecular mechanisms of glucocorticoid action and resistance

Journal of Steroid Biochemistry and Molecular Biology

Volumn 83, Issue 1-5, 2002, Pages 37-48

  Schaaf, Marcel J M ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Glucocorticoid; Glucocorticoid receptor; Homologous down regulation; NF B; Isoform

Indexed keywords

COMPLEMENTARY DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MESSENGER RNA; TRANSCRIPTION FACTOR; DNA; ISOPROTEIN;

CONFERENCE PAPER; DIMERIZATION; DNA BINDING; GENE ACTIVATION; GENE FUNCTION; GENE STRUCTURE; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR DOWN REGULATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSACTIVATION; ACTIVE TRANSPORT; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DOWN REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; REVIEW;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; DNA; DOWN-REGULATION; GLUCOCORTICOIDS; HUMANS; LIGANDS; MODELS, BIOLOGICAL; MODELS, GENETIC; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

EID: 0037643416     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00263-7     Document Type: Conference Paper

References (149)

1. Encio I.J., Detera-Wadleigh S.D. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266(11):1991;7182-7188.
2. Oakley R.H., Sar M., Cidlowski J.A. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271(16):1996;9550-9559.
3. Breslin M.B., Geng C.D., Vedeckis W.V. Multiple promoters exist in the human gr gene, one of which is activated by glucocorticoids. Mol. Endocrinol. 15(8):2001;1381-1395.
4. Zong J., Ashraf J., Thompson E.B. The promoter and first, untranslated exon of the human glucocorticoid receptor gene are GC rich but lack consensus glucocorticoid receptor element sites. Mol. Cell. Biol. 10(10):1990;5580-5585.
5. Nobukuni Y., Smith C.L., Hager G.L., Detera-Wadleigh S.D. Characterization of the human glucocorticoid receptor promoter. Biochemistry. 34(25):1995;8207-8214.
6. Breslin M.B., Vedeckis W.V. The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1. J. Steroid Biochem. Mol. Biol. 67(5-6):1998;369-381.
7. Webster J.C., Oakley R.H., Jewell C.M., Cidlowski J.A. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant-negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. U.S.A. 98(12):2001;6865-6870.
8. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompson E.B., Rosenfeld M.G., Evans R.M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318(6047):1985;635-641.
9. Weinberger C., Hollenberg S.M., Ong E.S., Harmon J.M., Brower S.T., Cidlowski J.A., Thompson E.B., Rosenfeld M.G., Evans R.M. Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science. 228(4700):1985;740-742.
10. Weinberger C., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature. 318(6047):1985;670-672.
11. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell. 46(5):1986;645-652.
12. Yudt M.R., Cidlowski J.A. Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol. Endocrinol. 15(7):2001;1093-1103.
13. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18(3):1997;306-360.
14. Pratt W.B., Dittmar K.D. Studies with purified chaperones advance the understanding of the mechanism of glucocorticoid receptor-hsp90 heterocomplex assembly. Trends Endocrinol. Metab. 9(6):1998;244-252.
15. Toft D.O. Recent advances in the study of hsp90 structure and mechanism of action. Trends Endocrinol. Metab. 9(6):1998;238-243.
16. Bresnick E.H., Dalman F.C., Sanchez E.R., Pratt W.B. Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. J. Biol. Chem. 264(9):1989;4992-4997.
17. Cadepond F., Schweizer-Groyer G., Segard-Maurel I., Jibard N., Hollenberg S.M., Giguere V., Evans R.M., Baulieu E.E. Heat shock protein 90 as a critical factor in maintaining glucocorticosteroid receptor in a nonfunctional state. J. Biol. Chem. 266(9):1991;5834-5841.
18. Howard K.J., Holley S.J., Yamamoto K.R., Distelhorst C.W. Mapping the HSP90 binding region of the glucocorticoid receptor. J. Biol. Chem. 265(20):1990;11928-11935.
19. Dalman F.C., Scherrer L.C., Taylor L.P., Akil H., Pratt W.B. Localization of the 90-kDa heat shock protein-binding site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J. Biol. Chem. 266(6):1991;3482-3490.
20. Xu M., Dittmar K.D., Giannoukos G., Pratt W.B., Simons S.S. Jr. Binding of hsp90 to the glucocorticoid receptor requires a specific seven amino acid sequences at the amino terminus of the hormone-binding domain. J. Biol. Chem. 273(22):1998;13918-13924.
21. Tai P.K., Albers M.W., Chang H., Faber L.E., Schreiber S.L. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science. 256(5061):1992;1315-1318.
22. Ray D.W., Suen C.S., Brass A., Soden J., White A. Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation. Mol. Endocrinol. 13(11):1999;1855-1863.
23. Lind U., Greenidge P., Gillner M., Koehler K.F., Wright A., Carlstedt-Duke J. Functional probing of the human glucocorticoid receptor steroid-interacting surface by site-directed mutagenesis. Gln-642 plays an important role in steroid recognition and binding. J. Biol. Chem. 275(25):2000;19041-19049.
24. Hurley D.M., Accili D., Stratakis C.A., Karl M., Vamvakopoulos N., Rorer E., Constantine K., Taylor S.I., Chrousos G.P. Point mutation causing a single amino acid substitution in the hormone-binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest. 87(2):1991;680-686.
25. Warriar N., Yu C., Govindan M.V. Hormone-binding domain of human glucocorticoid receptor. Enhancement of transactivation function by substitution mutants M565R and A573Q. J. Biol. Chem. 269(46):1994;29010-29015.
26. Lind U., Carlstedt-Duke J., Gustafsson J.A., Wright A.P. Identification of single amino acid substitutions of Cys-736 that affect the steroid-binding affinity and specificity of the glucocorticoid receptor using phenotypic screening in yeast. Mol. Endocrinol. 10(11):1996;1358-1370.
27. Lind U., Greenidge P., Gustafsson J.A., Wright A.P., Carlstedt-Duke J. Valine 571 functions as a regional organizer in programming the glucocorticoid receptor for differential binding of glucocorticoids and mineralocorticoids. J. Biol. Chem. 274(26):1999;18515-18523.
28. Robin-Jagerschmidt C., Wurtz J.M., Guillot B., Gofflo D., Benhamou B., Vergezac A., Ossart C., Moras D., Philibert D. Residues in the ligand-binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Mol. Endocrinol. 14(7):2000;1028-1037.
29. Hollenberg S.M., Evans R.M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell. 55(5):1988;899-906.
30. Orti E., Mendel D.B., Smith L.I., Munck A. Agonist-dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 264(17):1989;9728-9731.
31. Bodwell J.E., Orti E., Coull J.M., Pappin D.J., Smith L.I., Swift F. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J. Biol. Chem. 266(12):1991;7549-7555.
32. Bodwell J.E., Webster J.C., Jewell C.M., Cidlowski J.A., Hu J.M., Munck A. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65(1-6):1998;91-99.
33. Almlof T., Wright A.P., Gustafsson J.A. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J. Biol. Chem. 270(29):1995;17535-17540.
34. Krstic M.D., Rogatsky I., Yamamoto K.R., Garabedian M.J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17(7):1997;3947-3954.
35. Rogatsky I., Logan S.K., Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 95(5):1998;2050-2055.
36. Rogatsky I., Waase C.L., Garabedian M.J. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J. Biol. Chem. 273(23):1998;14315-14321.
37. Mason S.A., Housley P.R. Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. J. Biol. Chem. 268(29):1993;21501-21504.
38. Webster J.C., Jewell C.M., Bodwell J.E., Munck A., Sar M., Cidlowski J.A. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272(14):1997;9287-9293.
39. Cadepond F., Gasc J.M., Delahaye F., Jibard N., Schweizer-Groyer G., Segard-Maurel I., Evans R., Baulieu E.E. Hormonal regulation of the nuclear localization signals of the human glucocorticosteroid receptor. Exp. Cell Res. 201(1):1992;99-108.
40. Picard D., Yamamoto K.R. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6(11):1987;3333-3340.
41. Savory J.G., Hsu B., Laquian I.R., Giffin W., Reich T., Hache R.J., Lefebvre Y.A. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol. Cell. Biol. 19(2):1999;1025-1037.
42. Tsai S.Y., Carlstedt-Duke J., Weigel N.L., Dahlman K., Gustafsson J.A., Tsai M.J., O'Malley B.W. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell. 55(2):1988;361-369.
43. Wrange O., Eriksson P., Perlmann T. The purified activated glucocorticoid receptor is a homodimer. J. Biol. Chem. 264(9):1989;5253-5259.
44. Dahlman-Wright K., Siltala-Roos H., Carlstedt-Duke J., Gustafsson J.A. Protein-protein interactions facilitate DNA binding by the glucocorticoid receptor DNA-binding domain. J. Biol. Chem. 265(23):1990;14030-14035.
45. Dahlman-Wright K., Wright A., Gustafsson J.A., Carlstedt-Duke J. Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J. Biol. Chem. 266(5):1991;3107-3112.
46. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352(6335):1991;497-505.
47. Beato M., Chalepakis G., Schauer M., Slater E.P. DNA regulatory elements for steroid hormones. J. Steroid Biochem. 32(5):1989;737-747.
48. Beato M., Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17(6):1996;587-609.
49. Collingwood T.N., Urnov F.D., Wolffe A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endocrinol. 23(3):1999;255-275.
50. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20(3):1999;321-344.
51. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14(2):2000;121-141.
52. Jenkins B.D., Pullen C.B., Darimont B.D. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol. Metab. 12(3):2001;122-126.
53. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., Evans R.M. Role of CBP/P300 in nuclear receptor signalling. Nature. 383(6595):1996;99-103.
54. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85(3):1996;403-414.
55. Hanstein B., Eckner R., DiRenzo J., Halachmi S., Liu H., Searcy B., Kurokawa R., Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. U.S.A. 93(21):1996;11540-11545.
56. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270(5240):1995;1354-1357.
57. Yao T.P., Ku G., Zhou N., Scully R., Livingston D.M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. U.S.A. 93(20):1996;10626-10631.
58. Voegel J.J., Heine M.J., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15(14):1996;3667-3675.
59. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17(5):1997;2735-2744.
60. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90(3):1997;569-580.
61. Hittelman A.B., Burakov D., Iniguez-Lluhi J.A., Freedman L.P., Garabedian M.J. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 18(19):1999;5380-5388.
62. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature. 398(6730):1999;824-828.
63. Ito M., Yuan C.X., Malik S., Gu W., Fondell J.D., Yamamura S., Fu Z.Y., Zhang X., Qin J., Roeder R.G. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell. 3(3):1999;361-370.
64. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. U.S.A. 93(16):1996;8329-8333.
65. Fondell J.D., Guermah M., Malik S., Roeder R.G. Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc. Natl. Acad. Sci. U.S.A. 96(5):1999;1959-1964.
66. Deroo B.J., Archer T.K. Glucocorticoid receptor-mediated chromatin remodeling in vivo. Oncogene. 20(24):2001;3039-3046.
67. Fryer C.J., Archer T.K. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature. 393(6680):1998;88-91.
68. Sakai D.D., Helms S., Carlstedt-Duke J., Gustafsson J.A., Rottman F.M., Yamamoto K.R. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2(9):1988;1144-1154.
69. Morrison N., Eisman J. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J. Bone Miner. Res. 8(8):1993;969-975.
70. Cairns C., Cairns W., Okret S. Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element: evidence for the involvement of DNA-binding and agonistic effects of the antiglucocorticoid/antiprogestin RU486. DNA Cell Biol. 12(8):1993;695-702.
71. Drouin J., Trifiro M.A., Plante R.K., Nemer M., Eriksson P., Wrange O. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol. Cell. Biol. 9(12):1989;5305-5314.
72. Nakai Y., Usui T., Tsukada T., Takahashi H., Fukata J., Fukushima M., Senoo K., Imura H. Molecular mechanisms of glucocorticoid inhibition of human proopiomelanocortin gene transcription. J. Steroid Biochem. Mol. Biol. 40(1-3):1991;301-306.
73. Drouin J., Sun Y.L., Chamberland M., Gauthier Y., De Lean A., Nemer M., Schmidt T.J. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12(1):1993;145-156.
74. Diamond M.I., Miner J.N., Yoshinaga S.K., Yamamoto K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 249(4974):1990;1266-1272.
75. Pearce D., Yamamoto K.R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 259(5098):1993;1161-1165.
76. Harrison R.J., McNeil G.P., Dobner P.R. Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins. Mol. Endocrinol. 9(8):1995;981-993.
77. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62(6):1990;1189-1204.
78. Yang-Yen H.F., Chambard J.C., Sun Y.L., Smeal T., Schmidt T.J., Drouin J., Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62(6):1990;1205-1215.
79. Schule R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., Verma I.M., Evans R.M. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 62(6):1990;1217-1226.
80. De Bosscher K., Vanden Berghe W., Haegeman G. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15(2):2001;219-227.
81. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J.A., Van der Saag P.T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol. Endocrinol. 9(4):1995;401-412.
82. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 91(2):1994;752-756.
83. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., Baldwin A.S. Jr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15(2):1995;943-953.
84. McKay L.I., Cidlowski J.A. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 12(1):1998;45-56.
85. Tao Y., Williams-Skipp C., Scheinman R.I. Mapping of glucocorticoid receptor DNA-binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J. Biol. Chem. 276(4):2001;2329-2332.
86. Ito K., Jazrawi E., Cosio B., Barnes P.J., Adcock I.M. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J. Biol. Chem. 276(32):2001;30208-30215.
87. Nissen R.M., Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14(18):2000;2314-2329.
88. Svec F., Rudis M. Glucocorticoids regulate the glucocorticoid receptor in the AtT-20 cell. J. Biol. Chem. 256(12):1981;5984-5987.
89. Cidlowski J.A., Cidlowski N.B. Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells. Endocrinology. 109(6):1981;1975-1982.
90. Lacroix A., Bonnard G.D., Lippman M.E. Modulation of glucocorticoid receptors by mitogenic stimuli, glucocorticoids and retinoids in normal human cultured T cells. J. Steroid Biochem. 21(1):1984;73-80.
91. Sapolsky R.M., Krey L.C., McEwen B.S. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology. 114(1):1984;287-292.
92. Tornello S., Orti E., De Nicola A.F., Rainbow T.C., McEwen B.S. Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. Neuroendocrinology. 35(6):1982;411-417.
93. Schlechte J.A., Ginsberg B.H., Sherman B.M. Regulation of the glucocorticoid receptor in human lymphocytes. J. Steroid Biochem. 16(1):1982;69-74.
94. Dong Y., Poellinger L., Gustafsson J.A., Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and post-translational mechanisms. Mol. Endocrinol. 2(12):1988;1256-1264.
95. Hoeck W., Rusconi S., Groner B. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J. Biol. Chem. 264(24):1989;14396-14402.
96. Okret S., Poellinger L., Dong Y., Gustafsson J.A. Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc. Natl. Acad. Sci. U.S.A. 83(16):1986;5899-5903.
97. Rosewicz S., McDonald A.R., Maddux B.A., Goldfine I.D., Miesfeld R.L., Logsdon C.D. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J. Biol. Chem. 263(6):1988;2581-2584.
98. Vedeckis W.V., Ali M., Allen H.R. Regulation of glucocorticoid receptor protein and mRNA levels. Cancer Res. 49(Suppl. 8):1989;2295s-2302s.
99. Eisen L.P., Elsasser M.S., Harmon J.M. Positive regulation of the glucocorticoid receptor in human T-cells sensitive to the cytolytic effects of glucocorticoids. J. Biol. Chem. 263(24):1988;12044-12048.
100. Antakly T., Thompson E.B., O'Donnell D. Demonstration of the intracellular localization and up-regulation of glucocorticoid receptor by in situ hybridization and immunocytochemistry. Cancer Res. 49(Suppl. 8):1989;2230s-2234s.
101. Ashraf J., Kunapuli S., Chilton D., Thompson E.B. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells. J. Steroid Biochem. Mol. Biol. 38(5):1991;561-568.
102. Gomi M., Moriwaki K., Katagiri S., Kurata Y., Thompson E.B. Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA. Cancer Res. 50(6):1990;1873-1878.
103. Gruol D.J., Rajah F.M., Bourgeois S. Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells. Mol. Endocrinol. 3(12):1989;2119-2127.
104. Burnstein K.L., Jewell C.M., Sar M., Cidlowski J.A. Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms. Mol. Endocrinol. 8(12):1994;1764-1773.
105. Govindan M.V., Pothier F., Leclerc S., Palaniswami R., Xie B. Human glucocorticoid receptor gene promotor-homologous down regulation. J. Steroid Biochem. Mol. Biol. 40(1-3):1991;317-323.
106. Burnstein K.L., Jewell C.M., Cidlowski J.A. Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J. Biol. Chem. 265(13):1990;7284-7291.
107. Burnstein K.L., Bellingham D.L., Jewell C.M., Powell-Oliver F.E., Cidlowski J.A. Autoregulation of glucocorticoid receptor gene expression. Steroids. 56(2):1991;52-58.
108. Alksnis M., Barkhem T., Stromstedt P.E., Ahola H., Kutoh E., Gustafsson J.A., Poellinger L., Nilsson S. High level expression of functional full-length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J. Biol. Chem. 266(16):1991;10078-10085.
109. Meyer A.S., Schmidt T.J. Potential mechanisms underlying autoregulation of glucocorticoid receptor mRNA levels in the DHD/K12/PROb rat colonic adenocarcinoma cell line. J. Steroid Biochem. Mol. Biol. 55(2):1995;219-228.
110. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46(5):1986;659-667.
111. Chen C.Y., Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20(11):1995;465-470.
112. Schaaf M.J.M., Cidlowski J.A. AUUUA motifs in the 3(UTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression. Steroids. 67(7):2002;627-636.
113. McIntyre W.R., Samuels H.H. Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form. J. Biol. Chem. 260(1):1985;418-427.
114. Wallace A.D., Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 12:2001;12.
115. Bamberger C.M., Bamberger A.M., de Castro M., Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95(6):1995;2435-2441.
116. Oakley R.H., Webster J.C., Jewell C.M., Sar M., Cidlowski J.A. Immunocytochemical analysis of the glucocorticoid receptor alpha isoform (GRalpha) using GRalpha-specific antibody. Steroids. 64(10):1999;742-751.
117. Hecht K., Carlstedt-Duke J., Stierna P., Gustafsson J., Bronnegard M., Wikstrom A.C. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J. Biol. Chem. 272(42):1997;26659-26664.
118. Brogan I.J., Murray I.A., Cerillo G., Needham M., White A., Davis J.R. Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kappaB: lack of effect of glucocorticoid receptor beta. Mol. Cell. Endocrinol. 157(1-2):1999;95-104.
119. de Lange P., Koper J.W., Brinkmann A.O., de Jong F.H., Lamberts S.W. Natural variants of the beta isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids. Mol. Cell. Endocrinol. 153(1-2):1999;163-168.
120. Otto C., Reichardt H.M., Schutz G. Absence of glucocorticoid receptor-beta in mice. J. Biol. Chem. 272(42):1997;26665-26668.
121. de Castro M., Elliot S., Kino T., Bamberger C., Karl M., Webster E., Chrousos G.P. The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol. Med. 2(5):1996;597-607.
122. Oakley R.H., Webster J.C., Sar M., Parker C.R. Jr., Cidlowski J.A. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology. 138(11):1997;5028-5038.
123. Honda M., Orii F., Ayabe T., Imai S., Ashida T., Obara T., Kohgo Y. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 118(5):2000;859-866.
124. Mu Y.M., Takayanagi R., Imasaki K., Ohe K., Ikuyama S., Yanase T., Nawata H. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test. Clin. Endocrinol. (Oxf.). 49(3):1998;301-316.
125. Dahia P.L., Honegger J., Reincke M., Jacobs R.A., Mirtella A., Fahlbusch R., Besser G.M., Chew S.L., Grossman A.B. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J. Clin. Endocrinol. Metab. 82(4):1997;1088-1093.
126. Pujols L., Mullol J., Perez M., Roca-Ferrer J., Juan M., Xaubet A., Cidlowski J.A., Picado C. Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am. J. Respir. Cell Mol. Biol. 24(1):2001;49-57.
127. Strickland I., Kisich K., Hauk P.J., Vottero A., Chrousos G.P., Klemm D.J., Leung D.Y. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J. Exp. Med. 193(5):2001;585-594.
128. Longui C.A., Vottero A., Adamson P.C., Cole D.E., Kino T., Monte O., Chrousos G.P. Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia. Horm. Metab. Res. 32(10):2000;401-406.
129. Leung D.Y., Hamid Q., Vottero A., Szefler S.J., Surs W., Minshall E., Chrousos G.P., Klemm D.J. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J. Exp. Med. 186(9):1997;1567-1574.
130. Kam J.C., Szefler S.J., Surs W., Sher E.R., Leung D.Y. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151(7):1993;3460-3466.
131. Shahidi H., Vottero A., Stratakis C.A., Taymans S.E., Karl M., Longui C.A., Chrousos G.P., Daughaday W.H., Gregory S.A., Plate J.M. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. Biophys. Res. Commun. 254(3):1999;559-565.
132. Hamid Q.A., Wenzel S.E., Hauk P.J., Tsicopoulos A., Wallaert B., Lafitte J.J., Chrousos G.P., Szefler S.J., Leung D.Y. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am. J. Respir. Crit. Care Med. 159(5 Part 1):1999;1600-1604.
133. Sousa A.R., Lane S.J., Cidlowski J.A., Staynov D.Z., Lee T.H. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J. Allergy Clin. Immunol. 105(5):2000;943-950.
134. Christodoulopoulos P., Leung D.Y., Elliott M.W., Hogg J.C., Muro S., Toda M., Laberge S., Hamid Q.A. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J. Allergy Clin. Immunol. 106(3):2000;479-484.
135. Derijk R.H., Schaaf M.J., Turner G., Datson N.A., Vreugdenhil E., Cidlowski J.A., de Kloet E.R., Emery P., Sternberg E.M., Detera-Wadleigh S.D. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28(11):2001;2383-2388.
136. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., Cidlowski J.A. The dominant-negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 274(39):1999;27857-27866.
137. M.R. Yudt, C.M. Jewell, J.A. Cidlowski, The biochemical and structural basis for the dominant-negative function of human glucocorticoid receptor beta, manuscript in preparation.
138. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20(4):1999;435-459.
139. Baldwin A.S. Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
140. Fujita T., Nolan G.P., Ghosh S., Baltimore D. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 6(5):1992;775-787.
141. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
142. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science. 267(5203):1995;1485-1488.
143. Krappmann D., Wulczyn F.G., Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J. 15(23):1996;6716-6726.
144. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 388(6642):1997;548-554.
145. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89(3):1997;413-424.
146. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1(5):1998;661-671.
147. Doucas V., Shi Y., Miyamoto S., West A., Verma I.M., Evans R.M. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 97(22):2000;11893-11898.
148. McKay L.I., Cidlowski J.A. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol. Endocrinol. 14(8):2000;1222-1234.
149. Sheppard K.A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., Gerritsen M.E., Collins T. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273(45):1998;29291-29294.